Patenting Personalized Medicine After Prometheus July Web Conference

The key takeaways for this program are:

• Understanding the Prometheus decision and what the Supreme Court did and did not say;
• Understanding the question at issue in Myriad and how it is similar—and different—from that decided in Prometheus;
• Learning possible patent claim strategies to protect personalized medicine methods and biotechnology inventions under the new paradigm;
• Reviewing the U.S. Patent Office Guidance to Examiners, issued shortly after the Supreme Court decided Prometheus; and
• Discussing Options for strengthening already granted patents.